ATE257648T1 - Definierte medizinische lösung ohne serum für die augenheilkunde - Google Patents

Definierte medizinische lösung ohne serum für die augenheilkunde

Info

Publication number
ATE257648T1
ATE257648T1 AT99308702T AT99308702T ATE257648T1 AT E257648 T1 ATE257648 T1 AT E257648T1 AT 99308702 T AT99308702 T AT 99308702T AT 99308702 T AT99308702 T AT 99308702T AT E257648 T1 ATE257648 T1 AT E257648T1
Authority
AT
Austria
Prior art keywords
supplements
nutrient
solution
growth factor
medical solution
Prior art date
Application number
AT99308702T
Other languages
English (en)
Inventor
Debra L Skelnik
Original Assignee
Debra L Skelnik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debra L Skelnik filed Critical Debra L Skelnik
Application granted granted Critical
Publication of ATE257648T1 publication Critical patent/ATE257648T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/40—Nucleotides, nucleosides, bases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/135—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C12N2501/392—Sexual steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Environmental Sciences (AREA)
  • Biotechnology (AREA)
  • Dentistry (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99308702T 1998-11-05 1999-11-02 Definierte medizinische lösung ohne serum für die augenheilkunde ATE257648T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/186,580 US6153582A (en) 1998-11-05 1998-11-05 Defined serumfree medical solution for ophthalmology

Publications (1)

Publication Number Publication Date
ATE257648T1 true ATE257648T1 (de) 2004-01-15

Family

ID=22685497

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99308702T ATE257648T1 (de) 1998-11-05 1999-11-02 Definierte medizinische lösung ohne serum für die augenheilkunde

Country Status (9)

Country Link
US (1) US6153582A (de)
EP (1) EP1000541B1 (de)
JP (1) JP2000198701A (de)
AT (1) ATE257648T1 (de)
AU (1) AU769082B2 (de)
CA (1) CA2288540C (de)
DE (1) DE69914160T2 (de)
ES (1) ES2217700T3 (de)
PT (1) PT1000541E (de)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849612B2 (en) * 1993-01-21 2005-02-01 Isis Pharmaceuticals, Inc. Oligonucleotide modulation of cell adhesion
US20070231402A1 (en) 1994-08-02 2007-10-04 Immunopath Profile, Inc. Therapeutic stem cell composition and stimulant, facilitator, accelerator, and synergizer thereof, growth factor, anti-inflammatory composition and uses thereof
US6974796B1 (en) 1999-08-17 2005-12-13 Girsh Leonard S Therapeutic compositions for treatment of a damaged tissue
US20090274660A1 (en) 1999-08-17 2009-11-05 Immunopath Profile, Inc. Pluripotent therapeutic compositions and uses thereof
US20070037777A1 (en) * 2005-08-12 2007-02-15 Immunopath Profile, Inc. Lipid-containing compositions and methods of using them
US7790678B1 (en) 1999-08-17 2010-09-07 Immunopath Profile, Inc. Composition with anti-inflammatory, protein synthesizing, enzyme deficiency activating genetic therapy and anti-cancer activity and methods of use
CA2399505C (en) 2000-02-04 2012-01-03 Unigene Laboratories, Inc. Nasal calcitonin formulations
US6569615B1 (en) * 2000-04-10 2003-05-27 The United States Of America As Represented By The Department Of Veteran's Affairs Composition and methods for tissue preservation
US7611830B2 (en) * 2000-04-10 2009-11-03 The United States Of America As Represented By The Department Of Veteran's Affairs Device to lavage a blood vessel
US6762053B2 (en) * 2000-06-09 2004-07-13 Vitrolife, Inc. Mammalian gamete and embryo culture media and culture media supplements
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
CA2426885C (en) * 2000-11-14 2010-06-29 Vital Health Sciences Pty Ltd Complexes of phosphate derivatives
GB0028414D0 (en) 2000-11-22 2001-01-03 Univ Leeds Flush preservation solution
DE10133196A1 (de) * 2001-07-07 2003-01-23 Beiersdorf Ag Nicotinsäure enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
CN1547475B (zh) 2001-07-27 2010-12-15 生命健康科学有限公司 含电子转移试剂的磷酸酯衍生物的皮肤制剂
US20030077566A1 (en) * 2001-09-10 2003-04-24 Palasz Andrzej T. Method for cryopreserving mammalian cells and tissues
CA2467447A1 (en) * 2001-11-16 2003-06-05 Technocon Gmbh Method for biological treatment of water by adding macromolecular carbohydrates
BRPI0307074A2 (pt) * 2002-01-25 2017-06-20 Genzyme Corp meios sem soro para condrócitos e métodos para seu uso
CA2475356A1 (en) * 2002-02-12 2003-08-21 Raven Biotechnologies, Inc. Human fetal bladder-derived epithelial cells
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
EP1475434A1 (de) * 2003-05-09 2004-11-10 Oncoscience AG Verfahren zur Lagerung von Tumorzellen
FR2856891B1 (fr) * 2003-07-04 2007-09-07 Stem Alpha Milieu de conservation d'organes, de tissus biologiques ou de cellules vivantes
US20050176144A1 (en) * 2004-02-06 2005-08-11 O'daly Jose A. Culture media compositions free of fetal bovine serum
US20060281716A1 (en) 2004-03-03 2006-12-14 West Simon M Alkaloid formulations
BRPI0400935A (pt) * 2004-04-02 2005-11-22 Ernesto Rodriguez Salas Solução para conservação de membranas biológicas e seu uso
JP2005306749A (ja) * 2004-04-19 2005-11-04 Kringle Pharma Inc Ｈｇｆ含有臓器保存液
US8252591B2 (en) 2004-05-07 2012-08-28 Whitehead Institute For Biomedical Research Hormone responsive tissue culture system and uses thereof
US11660317B2 (en) 2004-11-08 2023-05-30 The Johns Hopkins University Compositions comprising cardiosphere-derived cells for use in cell therapy
CA2598792A1 (en) 2005-03-02 2006-09-08 Metanomics Gmbh Process for the production of fine chemicals
JP2008538752A (ja) * 2005-04-12 2008-11-06 クレオ コスメティック アンド ファーマスーティカルカンパニー エルエルシー 角膜組織を生体外保存するための組成物および方法
NZ565049A (en) 2005-06-17 2012-02-24 Vital Health Sciences Pty Ltd A carrier comprising one or more DI and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
CN100362098C (zh) * 2005-09-29 2008-01-16 华东理工大学 适用于多种动物细胞大规模培养的无血清培养基
US20070224588A1 (en) * 2006-03-22 2007-09-27 Biocept, Inc. Trophoblast preservation/pretreatment medium and method
EP2033513A1 (de) * 2006-05-30 2009-03-11 Instituto Nacional De Investigacion y Tecnologia agraria y Alimentaria (INIA) Vorgehensweise für die herstellung von unilamellaren vesikeln für die kryokonservierung und kultur von stammzellen und embryonen
CN100463681C (zh) * 2006-10-24 2009-02-25 北京紫竹药业有限公司 一种治疗干眼症的人工泪液
EP2124539A2 (de) * 2007-02-17 2009-12-02 President and Fellows of Harvard College Zusammensetzungen und verfahren zur gewebekonservierung
US20110244502A1 (en) 2007-08-10 2011-10-06 Whitehead Institute For Biomedical Research Hormone responsive tissue culture system and uses thereof
BRPI0908266A2 (pt) 2008-02-15 2015-07-21 Harvard College Solução substituta do sangue
JP5663841B2 (ja) * 2009-02-23 2015-02-04 富士レビオ株式会社 骨細胞への分化誘導培地及び方法
CN101524063B (zh) * 2009-03-23 2012-06-13 姚晓明 角膜中期保存液
MX2012000535A (es) 2009-07-10 2012-03-29 Linzy O Scott Iii Métodos y composiciones para tratar afecciones médicas relacionadas con la tiroides con folatos reducidos.
FR2948286B1 (fr) * 2009-07-27 2011-08-26 Jean-Noel Thorel Composition injectable associant un agent de comblement et un milieu de croissance des fibroblastes
JP5681472B2 (ja) * 2009-12-28 2015-03-11 ロート製薬株式会社 眼科用組成物
US10071030B2 (en) 2010-02-05 2018-09-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
WO2011103114A1 (en) * 2010-02-17 2011-08-25 Hememics Biotechnologies, Inc. Preservation solutions for biologics and methods related thereto
CA2794734C (en) 2010-03-30 2017-12-12 Phosphagenics Limited Transdermal delivery patch
US9845457B2 (en) * 2010-04-30 2017-12-19 Cedars-Sinai Medical Center Maintenance of genomic stability in cultured stem cells
EP2685992A4 (de) 2011-03-15 2014-09-10 Phosphagenics Ltd Aminochinoline als kinasehemmer
KR101664175B1 (ko) 2011-07-12 2016-10-11 푸드체크 시스템스, 아이엔씨. 살모넬라 및 대장균을 배양하기 위한 배양 배지, 방법 및 살모넬라 및 대장균을 검출하기 위한 방법
EP3563859B1 (de) 2012-08-13 2021-10-13 Cedars-Sinai Medical Center Von kardiosphären abgeleitete exosomen zur geweberegeneration
CA3153463A1 (en) 2012-10-29 2014-05-08 The University Of North Carolina At Chapel Hill Methods and compositions for treating mucosal tissue disorders
AU2013370268A1 (en) * 2012-12-31 2015-06-18 Somahlution, Llc Organ and tissue preservation formulations with increased stability and shelf life
CN103190392B (zh) * 2013-03-28 2015-07-29 北京大学第三医院 一种角膜中期保存液及其制备方法
US10350232B1 (en) 2013-11-04 2019-07-16 Peter D. Jaillet Medicinal drops
DK3027016T3 (da) 2013-11-22 2019-09-16 Somahlution Llc Opløsninger til øget stabilitet og holdbarhed for en organvævskonserveringsopløsning
JP6878274B2 (ja) 2014-10-03 2021-05-26 シーダーズ−サイナイ・メディカル・センターＣｅｄａｒｓ−Ｓｉｎａｉ Ｍｅｄｉｃａｌ Ｃｅｎｔｅｒ 筋ジストロフィーの処置における心筋球由来細胞およびこのような細胞によって分泌されたエキソソーム
JP6674462B2 (ja) * 2014-12-02 2020-04-01 アヴェドロ・インコーポレーテッドＡｖｅｄｒｏ，Ｉｎｃ． 眼の架橋処置のためのシステム、方法及び組成物
WO2016129654A1 (ja) * 2015-02-12 2016-08-18 国立大学法人 東京大学 角膜内皮前駆細胞の調製方法
ITUB20150108A1 (it) * 2015-03-04 2016-09-04 Alchilife S R L Molecola antimicotica sintetica e metodo per sintetizzare una molecola antimicotica
EP3277083A1 (de) 2015-04-03 2018-02-07 TX Innovations B.V. Organkonservierungszusammensetzung
FR3035407B1 (fr) 2015-04-23 2022-06-17 Francais Du Sang Ets Procede de conservation de cellules, tissus ou organes en hypothermie
FR3040860B1 (fr) * 2015-09-10 2020-05-15 Universite de Bordeaux Milieu de conservation injectable pour la conservation de cellules du sang placentaire, de la moelle osseuse et du sang peripherique
CN114712308A (zh) 2015-12-09 2022-07-08 磷肌酸有限公司 药物制剂
WO2017123662A1 (en) 2016-01-11 2017-07-20 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
US11351200B2 (en) 2016-06-03 2022-06-07 Cedars-Sinai Medical Center CDC-derived exosomes for treatment of ventricular tachyarrythmias
US10426796B2 (en) 2016-06-13 2019-10-01 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US10456423B2 (en) 2016-06-13 2019-10-29 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
EP3515459A4 (de) 2016-09-20 2020-08-05 Cedars-Sinai Medical Center Kardiosphärenzellen und deren extrazelluläre vesikel zur verzögerung oder umkehr des alterungsprozesses und altersbedingten erkrankungen
AU2017381395A1 (en) 2016-12-21 2019-06-20 Phosphagenics Limited Process
US10265312B1 (en) * 2018-02-01 2019-04-23 Jason Ahee Antibiotic solution and method of injection to prevent ophthalmic infections
US11759482B2 (en) 2017-04-19 2023-09-19 Cedars-Sinai Medical Center Methods and compositions for treating skeletal muscular dystrophy
EP3727351A4 (de) 2017-12-20 2021-10-06 Cedars-Sinai Medical Center Manipulierte extrazelluläre vesikel für verbesserte freisetzung in gewebe
CN108841780B (zh) * 2018-06-29 2019-03-12 陕西诺威利华生物科技有限公司 适合大规模生产pedv疫苗的无血清培养基
CN109801994B (zh) * 2019-01-09 2020-11-24 成都中建材光电材料有限公司 一种提升碲化镉电池性能的方法
US20220249399A1 (en) * 2019-03-04 2022-08-11 University Of Lowa Research Foundation Composition comprising an anti-oxidant to preserve corneal tissue
CN110278940A (zh) * 2019-07-11 2019-09-27 河南省农业科学院畜牧兽医研究所 一种猪精子保存剂及其制备方法和应用
US11904006B2 (en) 2019-12-11 2024-02-20 University Of Iowa Research Foundation Poly(diaminosulfide) particle-based vaccine
CN112602703B (zh) * 2020-12-17 2022-05-27 中山大学附属第三医院 一种细胞、组织或器官冷保存液的制备方法与应用
CN113508807B (zh) * 2021-08-05 2022-03-04 信阳农林学院 一种卵巢常温保存液及其保存方法
CN114190366B (zh) * 2021-12-29 2023-04-07 松山湖材料实验室 冻存液及其制备方法与在人正常肝细胞的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1263606A (en) * 1985-05-29 1989-12-05 Jeffrey P. Gilbard Non-toxic opthalmic preparations
CA2041828A1 (en) * 1990-03-05 1992-11-04 Richard L. Lindstrom Viscoelastic solution
EP0516901A1 (de) * 1991-06-06 1992-12-09 Richard L. Lindstrom Methode und Einrichtung für serumlose medizinische Lösung

Also Published As

Publication number Publication date
AU769082B2 (en) 2004-01-15
DE69914160T2 (de) 2004-09-02
EP1000541B1 (de) 2004-01-14
EP1000541A1 (de) 2000-05-17
PT1000541E (pt) 2004-08-31
US6153582A (en) 2000-11-28
ES2217700T3 (es) 2004-11-01
DE69914160D1 (de) 2004-02-19
JP2000198701A (ja) 2000-07-18
CA2288540C (en) 2011-07-05
AU5710899A (en) 2000-05-11
CA2288540A1 (en) 2000-05-05

Similar Documents

Publication Publication Date Title
ATE257648T1 (de) Definierte medizinische lösung ohne serum für die augenheilkunde
DE69114485D1 (de) Definierte medizinische Lösung ohne Serum und deren Verwendung.
US4725586A (en) Surgical solution
Ross et al. Enzymes of the γ-glutamyl cycle in the ciliary body and lens
CA2338541A1 (en) Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy
BR9814568A (pt) "inseminação sexual especìfica de mamìferos com baixo número de células espermatozóides"
FR2805821B1 (fr) Sequences d'acides amines facilitant la penetration d'une substance d'interet a l'interieur des cellules et/ou des noyaux cellulaires
ES2162331T3 (es) Utilizacion del factor de crecimiento del tejido nervioso para conservacion, cultivo o tratamiento de la cornea.
US5221537A (en) Tissue irrigating solutions
US5328701A (en) Tissue irrigation solution
Karlan et al. Potentiation of infections by biomaterials: a comparison of three materials
Boyd Sodium sulfathiazole iontophoresis
CN100562306C (zh) 含角质细胞生长因子-2的生物美容护肤品和重组人角质细胞生长因子-2的制备方法
US5380537A (en) Single irrigating solution used in ocular therapy for the endothelium protection and cornea preservation
Rizvi et al. The effect of pH and viscosity on bovine spermatozoa motility under controlled conditions
Cruz et al. A staging scheme for assessing development in vitro of organogenesis stage embryos of the stripe-faced dunnart, Sminthopsis macroura (Marsupialia: Dasyuridae)
Pincus Qualitative tests on human enamel protein
Mössinger In vitro cultivation of adult Litomosoides carinii: evaluation of basic culture media, gas phases and supplements
Huang et al. Effects of fertilization promoting peptide, adenosine, and pentoxifylline on thawed human sperm
US4083991A (en) Topical treatment of herpes infections with thimerosal
Correa-Pérez Embryo transfer medium—hyaluronic acid in place of albumin?
JPH1025201A (ja) 歯牙保存液
CN1853609A (zh) 酸性纤维母细胞生长因子（fgf－1）应用于护肤功效
Ueno et al. Ultrastructural observations of the retinal pigment epithelial cells following experimental occlusion of the posterior ciliary artery in the rhesus monkey. II. Mid-phase changes of the damaged retinal pigment epithelial cells (author's transl)
Bagchi et al. The effect of modified culture conditions on protein synthesis in the rabbit lens

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1000541

Country of ref document: EP